UnknownPhase 2NCT01698723

A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
All India Institute of Medical Sciences
Principal Investigator
Subrat K Acharya, DM
All India Institute of Medical Sciences
Intervention
Ribavirin(drug)
Enrollment
40 enrolled
Eligibility
12 years · All sexes
Timeline
20122016

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01698723 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials